Epigenetic polypharmacology: A new frontier for epi-drug discovery.

J. W. Fahey, Y. Zhang, P. Talalay, Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 10367- 10372 ,(1997) , 10.1073/PNAS.94.19.10367

Yann Neuzillet, Bas W. G. van Rhijn, Nadia L. Prigoda, Bharati Bapat, Liyang Liu, Peter J. Bostrom, Neil E. Fleshner, Brenda L. Gallie, Alexandre R. Zlotta, Michael A. S. Jewett, Theo H. van der Kwast, FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer Virchows Archiv. ,vol. 465, pp. 207- 213 ,(2014) , 10.1007/S00428-014-1596-4

S Negrotto, K P Ng, A M Jankowska, J Bodo, B Gopalan, K Guinta, J C Mulloy, E Hsi, J Maciejewski, Y Saunthararajah, CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors Leukemia. ,vol. 26, pp. 244- 254 ,(2012) , 10.1038/LEU.2011.207

Todd S. Weiser, Z. Sheng Guo, Galen A. Ohnmacht, Maria L. Parkhurst, Panida Tong-On, Francesco M. Marincola, Maria R. Fischette, Xiaodan Yu, G. Aaron Chen, Julie A. Hong, John H. Stewart, Dao M. Nguyen, Steven A. Rosenberg, David S. Schrump, Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. Journal of Immunotherapy. ,vol. 24, pp. 151- 161 ,(2001) , 10.1097/00002371-200103000-00010

Anne von Heideman, Åke Berglund, Rolf Larsson, Peter Nygren, Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemotherapy and Pharmacology. ,vol. 65, pp. 1165- 1172 ,(2010) , 10.1007/S00280-009-1125-3

Maria Traka, Karen Chambers, Elizabeth Lund, Robert Goodlad, Ian Johnson, Richard Mithen, Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21(waf1/cip1). Nutrition and Cancer. ,vol. 61, pp. 137- 145 ,(2009) , 10.1080/01635580802348641

Richard Morphy, Zoran Rankovic, Designed multiple ligands. An emerging drug discovery paradigm. Journal of Medicinal Chemistry. ,vol. 48, pp. 6523- 6543 ,(2005) , 10.1021/JM058225D

Richard J. Hopkinson, Anthony Tumber, Clarence Yapp, Rasheduzzaman Chowdhury, WeiShen Aik, Ka Hing Che, Xuan Shirley Li, Jan B. L. Kristensen, Oliver N. F. King, Mun Chiang Chan, Kar Kheng Yeoh, Hwanho Choi, Louise J. Walport, Cyrille C. Thinnes, Jacob T. Bush, Clarisse Lejeune, Anna M. Rydzik, Nathan R. Rose, Eleanor A. Bagg, Michael A. McDonough, Tobias J. Krojer, Wyatt W. Yue, Stanley S. Ng, Lars Olsen, Paul E. Brennan, Udo Oppermann, Susanne Müller, Robert J. Klose, Peter J. Ratcliffe, Christopher J. Schofield, Akane Kawamura, 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation Chemical Science. ,vol. 4, pp. 3110- 3117 ,(2013) , 10.1039/C3SC51122G

Shi-Wei Chao, Hui-Wen Chiu, Ya-Ling Yeh, Hsin-Yi Chang, Hsueh-Fen Juan, Pinpin Lin, Yi-Ching Wang, Wei-Jan Huang, Yen-An Tang, Mei-Yu Chen, Ying-Jan Wang, Fu-Han Hu, Tseng-Wei Wang, A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies Cancer Letters. ,vol. 346, pp. 84- 93 ,(2014) , 10.1016/J.CANLET.2013.12.016

Christophe F Deroanne, Karine Bonjean, Sandrine Servotte, Laetitia Devy, Alain Colige, Nathalie Clausse, Sylvia Blacher, Eric Verdin, Jean-Michel Foidart, Betty V Nusgens, Vincent Castronovo, Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling Oncogene. ,vol. 21, pp. 427- 436 ,(2002) , 10.1038/SJ.ONC.1205108